Keywords: sanofi-aventis, withdraws, maa, aquilda, crucial, new, data

Sanofi-Aventis withdraws MAA for Aquilda; crucial new data expected before 2009

Article | 02 June 2008

French drug major Sanofi-Aventis has withdrawn its European centralized marketing authorization application for Aquilda (satavaptan) after the European Medicines Agency's ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Go to company listing